Welcome to our dedicated page for OrthoPediatrics news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on OrthoPediatrics stock.
OrthoPediatrics Corp. develops and commercializes medical devices for pediatric orthopedics, with products used in trauma and deformity, scoliosis, sports medicine and related procedures. Company news commonly covers quarterly financial results, revenue by product category, domestic and international sales trends, cash-flow metrics and updates to financial guidance.
Recurring product and market updates include specialty bracing, spine and deformity correction systems, implants, instruments and enabling technologies for pediatric care. Announcements also include investor conference participation and portfolio additions such as hospital-based traction systems and other products aimed at children with orthopedic conditions.
OrthoPediatrics Corp. (KIDS) reported first-quarter 2020 revenues of $16.4 million, up 11.6% from $14.7 million in Q1 2019. Domestic revenue rose 30.4% to $13.4 million, while international revenue fell 32.3% to $3.0 million. The company acquired ApiFix and launched new products, expanding its portfolio. However, it suspended its full-year 2020 revenue guidance due to COVID-19 uncertainties. Operating loss increased to ($4.5 million), and net loss attributable to common stockholders was ($4.9 million), or ($0.30) per share.